Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Abbot, ACE, acetaminophen, acquiredBreathe, activitiesundertaken, ActoplusMet, addedFluviralto, aggressivecompetition, agreementfor, alpha, alternativeaccounting, ambrisentan, Amgen, andAvandamet, andEntereg, andEpivirdown, andFiberChoicedaily, andFiberChoicedietary, andImigran, andjoint, andLexivaup, andPaxil, andRedonafor, andRotarix, andTreximafor, andZofranentered, angiotensin, anti, areLucozadeenergy, arterialhypertension, atypical, auditinformation, Avandiaproduct, awareof, baseline, biennial, birth, BlackRock, bone, boughtPaxilfor, brecanavir, broader, Buhrmann, Bulletin, Cameroon, carbamazepine, cathepsin, CEEDD, Century, CFC, ChemoCentryx, CIC, clearance, congenital, continent, contributor, Corning, corticotrophin, COSO, CRin, criticalaccounting, Croatia, curtain, Cymbalta, Daniel, dashboard, defect, derecognition, deteriorate, determinetheir, Dilantin, dilator, disclosureof, disclosureson, dishonest, DOJ, Dow, drifted, drop, DSM, Duncan, Dystrophy, emission, endothelin, enrolled, eosinophilic, EPIX, ER, escalation, fear, Ferrari, fibre, flair, Ford, forfeiture, forget, forImigranandZofranwhilst, forLamictalin, formalised, formulationRequip, forPaxil, forPaxilpurchased, forpreventing, Friday, gamma, Gastroenterological, Gastroenterology, Genmab, gently, givea, Globorix, GPO, Greece, Groupat, Hamilton, harbour, hard, Harvard, hay, headcount, Healthcaremarketing, hub, humour, hypogonadism, IASRegulation, immunisation, immunogenicity, improvedperformance, includingalli, Ineffective, insignificant, integrin, inthe, Iowa, IRandWellbutrinhad, IRin, iron, irrevocable, irritable, Israel, Jennie, Keppra, KPMG, Labor, Laval, Learmouth, Lebanon, leukaemia, lift, Lithium, longest, Louv, lump, lymphoblastic, lymphocycte, lymphocytic, Mab, Macrolide, Madison, magnetic, Majesty, maker, Mallinkrodt, marketsBreathe, Maxalt, MDR, menopausal, Merrell, mindful, MMRV, Montrose, morale, MPL, MrHeslop, Muscular, Myogen, namealli, neglected, neurophysiology, newborn, Nippon, nonfringement, normalised, OECD, oestrogen, ofalli, ofAquafreshwere, ofCervarix, ofCoreg, ofFluLavalfollowing, ofFlulavalin, ofHavrix, ofLamictal, ofPaxilduring, ofRedonafor, ofRequip, ofRotarix, ofSeroxatdown, ofSynflorix, ofwhich, ofZantacin, ofZyrtec, onLamictal, onPaxilinstant, outweigh, overfunded, overtime, oxygen, pancreatic, payout, perfect, pertain, phenytoin, piece, Pigmentosa, pneumoniaeelderly, Podolsky, Polfa, pollen, portfolioBreathe, positron, possessing, postmenopausal, Poznan, PPAR, pregnancy, preparedto, PricewaterhouseCoopersLLP, principlescontinued, privatelabel, proactive, purchasingPaxilfor, quantification, quarterlyand, Quebec, radiochemistry, reassessed, reassessment, refinancing, refuse, reissued, reload, Relpax, remodelled, remodelling, reperformed, reprisal, ResearchInstitute, residual, Revolution, revolutionising, Rightnasal, risky, Russian, RxUSA, score, scored, Sensex, Seroquel, sertraline, seventeenth, SICK, simpler, slipped, slowdown, stakeholder, steadily, Stephanie, strengthenedtheir, submittedLamictal, sulphonylurea, SVP, Switzerland, Synflorix, Tajikistan, takingreasonable, talk, Talking, tender, termsof, testimony, testosterone, thanAgenerase, thatAvandiacan, thatPaxil, theAvandiagroup, theavandiaproduct, theAvandiarange, thecompany, theend, theirrelease, thepublic, thepublished, theremuneration, theWellbutrin, threshold, toAdvair, toFluarixGSK, toLamictalandPaxil, tomography, tonne, tookPaxilafter, tookPaxilduring, TORCH, toreview, Toronto, tough, toZofranandWellbutrin, toZofranentered, traditionally, Treadway, trimester, trimmed, tumour, Tykerb, UCB, unauthorized, unaware, underarticle, underfunded, unethical, unforeseen, unplanned, unresolved, valacyclovir, variation, Village, vitronectin, VOC, waiting, week, whereRotarixwill, whichdisclose, whopping, wider, wife, willeach, win, withmanagement, withPanadoland, workshop, XLand, XLcommenced, XLduring, XLthat, XRat, ZA, Zagreb, Zofranand, Zofranprovided, Zomig, Zurich
Removed:
abolished, accomplishment, advisor, aiming, ambition, Anacor, answer, anticipatory, arriving, art, automation, Avaxim, Beckman, begin, birthday, buyout, cannibalisation, climbing, Comvax, consolidate, Continental, continually, correlation, crystal, damage, deficiency, demonstrating, depend, Developmental, doctoral, dysphoric, East, emerging, Eon, eventual, exciting, exclude, Fabre, faster, Faulding, Fax, finalised, Flamel, formulating, fostering, FRS, FSP, GCS, gene, Govett, greatest, guarantor, HB, Hoare, indisputable, Inland, inspire, intellect, intent, internationally, interrupted, Iraq, job, John, LIBOR, Ludwig, medication, Michigan, Microbial, microbiology, monopolize, monopolizing, muscarinic, musculoskeletal, nabumetone, NCE, nominate, notable, operandi, packaged, pathological, perspective, phased, Pierre, planned, poorest, postal, premenstrual, productive, Proliferative, prove, pursuing, quickly, rationalisation, reassured, Recombivax, recovery, Relafen, removing, renew, resilient, retiring, rich, Rockefeller, screening, securing, Seretide, sliding, SSAP, stating, stimulate, subdued, sustain, systematic, Task, telephoning, tension, tissue, transitional, treaty, undefined, underpin, validated, Vaqta, Virginia, West, workplace, WWD
Filing tables
GSK similar filings
Filing view
External links
Exhibit 13.1
Section 906 Certificate
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of GlaxoSmithKline plc, a public limited company incorporated under English law (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 20-F for the year ended December 31, 2006 (the “Form 20-F”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 2, 2007 | /s/ Jean-Pierre Garnier | ||
Dr. Jean-Pierre Garnier | |||
Chief Executive Officer |
Date: March 2, 2007 | /s/ Julian Heslop | ||
Julian Heslop | |||
Chief Financial Officer |